Two University of Central Florida (UCF) cancer researchers were bestowed state grants to support their innovative projects to fight breast cancer. Alicja Copik and Debbie Altomare each received $100,000 from the Florida Breast Cancer Foundation (FBCF) for their research, which aims to create novel and effective ways of diagnosing and treating breast cancer.
Advertisement
There is a need to identify prognostic biomarkers of IgA nephropathy (IgAN) that can be used in clinical practice.
A study identified possible prognostic factors and survival patterns based on histology type in endometrial cancer patients.
The CMMI renewed its contract with Phreesia to use the Patient Activation Measure to support the Kidney Care Choices Model.
Efficacy and safety primary analysis findings are reported from the international, open-label FREEDOM2 trial.
The CheckMate 77T trial evaluated the efficacy of adjuvant and neoadjuvant nivolumab in resectable, untreated NSCLC.
A new study addresses the need for data on treatment outcomes in patients younger than 12 years of age.
Robert E. Merritt, MD, MBA, FACS, discusses the analysis he presented at the IASLC 2024 World Conference on Lung Cancer.
Critical Financial Shifts Ahead: How CY 2025 ESRD PPS Changes Could Impact Small Dialysis Facilities
Sarah Tolson reviews the key financial implications of the CMS proposed rule for the ESRD Prospective Payment System.DocWire Content Partners
Gain insights from The CardioNerds, a group of cardiology experts who aim to democratize cardiovascular education.
Fundamentals, core concepts, and important management approaches in the field of hematology and oncology
Dr. Chadi Nabhan, a renowned voice in hematology and oncology, tackles a multitude of relevant health care topics.
Drs. Rohit Gosain and Rahul Gosain discuss practice-changing data and standards of oncology care.
Dr. Hady Lichaa is an interventional cardiologist specializing in complex coronary interventions.
Review important issues in the rheumatology space, including lupus, rheumatoid arthritis, and more, from Dr. Maheswaranathan.
Powered by DocWire News
The Latest From GI Oncology Now
Dr. Wungki Park gives an overview of the POLAR study for metastatic pancreatic cancer.
Dr. Wungki Park of Memorial Sloan Kettering Cancer Center discusses his trial on the use of ASP3082 for solid tumors.
While biliary tract cancer is one of the fastest-growing types of early-onset cancers, little is known about its biology.
Little is known about the details of genomic differences and clinical implications between patients with GISTs.
The FAK inhibitor narmafotinib targets solid tumors in pancreatic cancer.
Retifanlimab plus chemotherapy showed improved PFS and response rates in locally recurrent or metastatic SCAC.
The Latest From Heme Today
Efficacy and safety primary analysis findings are reported from the international, open-label FREEDOM2 trial.
A new study addresses the need for data on treatment outcomes in patients younger than 12 years of age.
Levels for certain inflammation biomarkers in patients with MDS were similar to in patients with autoinflammatory disorders.
In pediatric, adolescent, and young adult patients, hematopoietic stem cell transplant was found to bolster overall survival.
The most common serious treatment-emergent adverse event among patients receiving either therapy was pneumonia.
A phase II trial calculated a 4-year event-free survival rate of 96% and overall survival rate of 100% from the combination.
